Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-κB-dependent process in human cervical carcinoma cells

Cancer Letters

Volumn 229, Issue 1, 2005, Pages 49-57

  Im, Eunok ^a   Choi, Sang Ho ^a   Suh, Hongsuk ^a   Yung, Hyun Choi ^b   Young, Hyun Yoo ^c   Nam, Deuk Kim ^a  

^a Pusan National University   (South Korea)

^b Dong Eui University   (South Korea)

^c Dong A University College of Medicine   (South Korea)

Author keywords

AP 1; Apoptosis; Bile acid derivatives; c Jun N terminal kinase; NF B; SiHa

Indexed keywords

CHENODEOXYCHOLIC ACID DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; STRESS ACTIVATED PROTEIN KINASE; URSODEOXYCHOLIC ACID DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSCRIPTION TERMINATION; UTERINE CERVIX CARCINOMA;

APOPTOSIS; BILE ACIDS AND SALTS; CARCINOMA; CELL PROLIFERATION; CHENODEOXYCHOLIC ACID; DNA DAMAGE; ENZYME ACTIVATION; FEMALE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHORYLATION; TUMOR CELLS, CULTURED; URSODEOXYCHOLIC ACID; UTERINE CERVICAL NEOPLASMS;

EID: 24344482024     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.11.055     Document Type: Article

References (51)

1. L. McMillan, S. Butcher, Y. Wallis, J.P. Neoptolemos, and J.M. Lord Bile acids reduce the apoptosis-inducing effects of sodium butyrate on human colon adenoma (AA/C1) cells: implications for colon carcinogenesis Biochem. Biophys. Res. Commun. 273 2000 45 49
2. T. Narisawa, N.E. Magadia, J.H. Weinburger, and E.L. Wynder Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N′-nitro-N-nitrosoguanidine in rats J. Natl Cancer Inst. 53 1974 1093 1097
3. B.S. Reddy, and K. Watanabe Effect of cholesterol metabolites and promoting effect of lithocholic acid in colon carcinogenesis in germ-free and conventional F344 rats Cancer Res. 39 1979 1521 1524
4. J.D. Martinez, E.D. Stratagoules, J.M. LaRue, A.A. Powell, P.R. Gause, and M.T. Craven Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation Nutr. Cancer 31 1998 111 118
5. W.A. Faubion, M.E. Guicciardi, H. Miyoshi, S.F. Bronk, P.J. Roberts, and P.A. Svingen Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas J. Clin. Invest. 103 1999 137 145
6. N.N. Mahmoud, A.J. Dannenberg, R.T. Bilinski, J.R. Mestre, A. Chadburn, and M. Churchill Administration of an unconjugated bile acid increases duodenal tumors in a murine model of familial adenomatous polyposis Carcinogenesis 20 1999 299 303
7. T. Sodeman, S.F. Bronk, P.J. Roberts, H. Miyoshi, and G.J. Gores Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas Am. J. Physiol. Gastrointest. Liver Physiol. 278 2000 G992 G999
8. M. Makishima, A.Y. Okamoto, J.J. Repa, H. Tu, R.M. Learned, and A. Luk Identification of a nuclear receptor for bile acids Science 284 1999 1362 1365
9. D.J. Parks, S.G. Blanchard, R.K. Bledsoe, G. Chandra, T.G. Consler, and S.A. Kliewer Bile acids: natural ligands for an orphan nuclear receptor Science 284 1999 1365 1368
10. H. Wang, J. Chen, K. Hollister, L.C. Sowers, and B.M. Forman Endogenous bile acids are ligands for the nuclear receptor FXR/BAR Mol. Cell 3 1999 543 553
11. C. Rust, L.M. Karnitz, C.V. Paya, J. Moscat, R.D. Simari, and G.J. Gores The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade J. Biol. Chem. 275 2000 20210 20216
12. C.S. Song, I. Echchgadda, B.S. Baek, S.C. Ahn, T. Oh, A.K. Roy, and B. Chatterjee Dehydroepiandrosterone sulfotransferase gene induction by bile acid activated farnesoid X receptor J. Biol. Chem. 276 2001 42549 42556
13. D.L. Earnest, H. Holubec, R.K. Wali, C.S. Jolley, M. Bissonette, and A.K. Bhattacharyya Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid Cancer Res. 54 1994 5071 5074
14. R.F. Silva, C.M. Rodrigues, and D. Brites Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid J. Hepatol. 34 2001 402 408
15. D.M. Heuman, and R. Bajaj Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts Gastroenterology 106 1994 1333 1341
16. C.M. Rodrigues, G. Fan, X. Ma, B.T. Kren, and C.J. Steer A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation J. Clin. Invest. 101 1998 2790 2799
17. M.J. Czaja The future of GI and liver research: editorial perspectives. III. JNK/AP-1 regulation of hepatocyte death Am. J. Physiol. Gastrointest. Liver Physiol. 284 2003 G875 G879
18. B. Glinghammar, K. Holmberg, and J. Rafter Effects of colonic lumenal components on AP-1-dependent gene transcription in cultured human colon carcinoma cells Carcinogenesis 20 1999 969 976
19. L.M. Brady, D.W.A. Beno, and B.H. Davis Bile acid stimulation of early growth response gene and mitogen-activated protein kinase is protein kinase C-dependent Biochem. J. 316 1996 756 769
20. D. Qiao, W. Chen, E.D. Stratagoules, and J.D. Martinez Bile acid-induced activation of activator protein-1 requires both extracellular signal-regulated kinase and protein kinase C signaling J. Biol. Chem. 275 2000 15090 15098
21. H. Higuchi, A. Grambihler, A. Canbay, S.F. Bronk, and G.J. Gores Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1 J. Biol. Chem. 279 2004 51 60
22. N.D. Kim, E.O. Im, Y.H. Choi, and Y.H. Yoo Synthetic bile acids: novel mediators of apoptosis J. Biochem. Mol. Biol. 35 2002 134 141
23. J.H. Baek, J. Kim, C. Kang, Y.S. Lee, and K.W. Kim Induction of apoptosis by bile acids in HepG2 human hepatocellular carcinoma cells Korean J. Physiol. Pharmacol. 1 1997 107 115
24. Y.H. Park, J. Kim, J. Baek, E. Jung, T. Kim, and H. Suh Induction of apoptosis in HepG2 human hepatocellular carcinoma cells by a novel derivative of ursodeoxycholic acid (UDCA) Arch. Pharm. Res. 20 1997 29 33
25. E.O. Im, S. Lee, H. Suh, K.W. Kim, Y.T. Bae, and N.D. Kim A novel ursodeoxycholic acid derivative induces apoptosis in human MCF-7 breast cancer cells Pharm. Pharmacol. Commun. 5 1999 293 298
26. E.O. Im, Y.H. Choi, K.J. Paik, H. Suh, Y. Jin, and K.W. Kim Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells Cancer Lett. 163 2001 83 93
27. Y.H. Choi, E.O. Im, H. Suh, Y. Jin, W.H. Lee, and Y.H. Yoo Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases Int. J. Oncol. 18 2001 979 984
28. Y.H. Choi, E.O. Im, H. Suh, Y. Jin, Y.H. Yoo, and N.D. Kim Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells Cancer Lett. 199 2003 157 167
29. S.E. Park, H.J. Choi, S.B. Yee, H.Y. Chung, H. Suh, and Y.H. Choi Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human colon cancer cells Int. J. Oncol. 25 2004 231 236
30. D.K. Kim, J.R. Lee, A. Kim, S. Lee, M.A. Yoo, and K.W. Kim Inhibition of initiation of simian virus 40 DNA replication in vitro by the ursodeoxycholic acid and its derivatives Cancer Lett. 146 1999 147 153
31. B.A. Werness, A.J. Levine, and P.M. Howley Association of human papillomavirus types 16 and 18 E6 proteins with p53 Science 248 1990 76 79
32. X.H. Liang, S. Mungal, A. Ayscue, J.D. Meissner, P. Wodnicki, and D. Hockenbery Bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53 J. Cell. Biochem. 57 1995 509 521
33. H. Tada, O. Shiho, K. Kuroshima, M. Koyama, and K. Tsukamoto An improved colorimetric assay for interleukin 2 J. Immunol. Methods 93 1986 157 165
34. S. Lee, Y.S. Cho, C. Shim, J. Kim, J. Choi, and S. Oh Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-β in the SiHa human cervical carcinoma cell line Int. J. Cancer 94 2001 500 507
35. B. Liu, M. Fang, Y. Lu, Y. Lu, G.B. Mills, and Z. Fan Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells Br. J. Cancer 85 2001 303 311
36. S. Leppä, and D. Bohmann Diverse functions of JNK signaling and c-Jun in stress response and apoptosis Oncogene 18 1999 6158 6162
37. P. Juin, A.O. Hueber, T. Littlewood, and G. Evan c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release Genes Dev. 13 1999 1367 1381
38. K. Noguchi, C. Kitanaka, H. Yamana, A. Kokubu, T. Mochizuki, and Y. Kuchino Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase J. Biol. Chem. 274 1999 32580 32587
39. G.S. Salomons, H.J. Brady, M. Verwijs-Janssen, J.D. Van Den Berg, A.A. Hart, and H. Van Den Berg The Baxα:Bcl-2 ratio modulates the response to dexamethasone in leukaemic cells and is highly variable in childhood acute leukaemia Int. J. Cancer 71 1997 959 965
40. Y. Luo, A. Hattori, J. Munoz, Z. Qin, and G.S. Roth Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-κB in rats Mol. Pharmacol. 56 1999 254 264
41. P.F. Johnson, and S.L. McKnight Eukaryotic transcriptional regulatory proteins Annu. Rev. Biochem. 58 1989 799 839
42. T. Smeal, B. Binetruy, D.A. Mercola, M. Birrer, and M. Karin Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73 Nature 354 1991 494 496
43. Z. Xia, M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326 1331
44. A. Grambihler, H. Higuchi, S.F. Bronk, and G.J. Gores cFLIP-L inhibits p38 MAPK activation. An additional anti-apoptotic mechanism in bile acid-mediated apoptosis J. Biol. Chem. 278 2003 26831 26837
45. R. Reinehr, and D. Häussinger Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95 Gastroenterology 126 2004 249 262
46. H. Ichijo From receptors to stress-activated MAP kinases Oncogene 18 1999 6087 6093
47. C.S. Hill, and R. Treisman Transcriptional regulation by extracellular signals: mechanisms and specificity Cell 80 1995 199 211
48. B. Kaltschmidt, C. Kaltschmidt, T.G. Hofmann, S.P. Hehner, W. Dröge, and M.L. Schmitz The pro- or anti-apoptotic function of NF-κB is determined by the nature of the apoptotic stimulus Eur. J. Biochem. 267 2000 3828 3835
49. S. Shishodia, and B.B. Aggarwal Nuclear factor-κB: a friend or a foe in cancer? Biochem. Pharmacol. 68 2004 1071 1080
50. H. Higuchi, and G.J. Gores Bile acid regulation of hepatic physiology. IV. Bile acids and death receptors Am. J. Physiol. Gastrointest. Liver Physiol. 284 2003 G734 G738
51. A. Di Cristofano, P. Kotsi, Y.F. Peng, C. Cordon-Cardo, K.B. Elkon, and P.P. Pandolfi Impaired Fas response and autoimmunity in Pten+/- mice Science 285 1999 2122 2125